Literature DB >> 3235566

Determination of tacrine hydrochloride in human serum by chloroform extraction, reversed-phase high-performance liquid chromatography and fluorimetric detection.

D R Forsyth1, J M Ford, C A Truman, C J Roberts, G K Wilcock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3235566     DOI： 10.1016/s0378-4347(00)80620-9

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  5 in total

1.  Bioavailability and pharmacokinetic disposition of tacrine in elderly patients with Alzheimer's disease.

Authors:  G Lou; P R Montgomery; D S Sitar
Journal:  J Psychiatry Neurosci       Date:  1996-11       Impact factor: 6.186

2.  Distribution of tacrine across the blood-brain barrier in awake, freely moving rats using in vivo microdialysis sampling.

Authors:  M Telting-Diaz; C E Lunte
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

3.  Characteristics of plasma protein binding of tacrine hydrochloride: a new drug for Alzheimer's disease.

Authors:  P M Mäkelä; C A Truman; J M Ford; C J Roberts
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

4.  Measurements of tacrine and monoamines in brain by in vivo microdialysis argue against release of monoamines by tacrine at therapeutic doses.

Authors:  H A Baldwin; R J De Souza; G S Sarna; T K Murray; A R Green; A J Cross
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

Review 5.  Clinical pharmacokinetics of tacrine.

Authors:  S Madden; V Spaldin; B K Park
Journal:  Clin Pharmacokinet       Date:  1995-06       Impact factor: 6.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.